{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:50:12Z","timestamp":1790423412823,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K005537\/1"],"award-info":[{"award-number":["MR\/K005537\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.neuropharm.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T08:01:03Z","timestamp":1518422463000},"page":"23-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"PA","title":["Probing GABAA receptors with inhibitory neurosteroids"],"prefix":"10.1016","volume":"136","author":[{"given":"Sandra","family":"Seljeset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian P.","family":"Bright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor G.","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.02.008_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1469-7793.2001.0673e.x","article-title":"Pregnenolone sulfate block of GABAA receptors: mechanism and involvement of a residue in the M2 region of the \u03b1 subunit","volume":"532","author":"Akk","year":"2001","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib2","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1523\/JNEUROSCI.4173-05.2005","article-title":"Neurosteroid access to the GABAA receptor","volume":"25","author":"Akk","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2007.03.004","article-title":"Mechanisms of neurosteroid interactions with GABAA receptors","volume":"116","author":"Akk","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1124\/mol.108.048520","article-title":"Mutations of the GABAA receptor \u03b11 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids","volume":"74","author":"Akk","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib5","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.psyneuen.2009.05.020","article-title":"The influence of the membrane on neurosteroid actions at GABAA receptors","volume":"34","author":"Akk","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABAA receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0028-3908(02)00172-7","article-title":"The influence of subunit composition on the interaction of neurosteroids with GABAA receptors","volume":"43","author":"Belelli","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1523\/JNEUROSCI.2996-10.2011","article-title":"Profound desensitization by ambient GABA limits activation of \u03b4-containing GABAA receptors during spillover","volume":"31","author":"Bright","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human \u03b14\u03b23\u03b4 GABAA receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1124\/mol.106.028332","article-title":"Voltage-dependent block of N-Methyl-D-aspartate receptors by dopamine D1 receptor ligands","volume":"70","author":"Cui","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.bjp.0700987","article-title":"Modulation by general anaesthetics of rat GABAA receptors comprised of \u03b11\u03b23 and \u03b23 subunits expressed in human embryonic kidney 293 cells","volume":"120","author":"Davies","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1113\/jphysiol.2003.043810","article-title":"Activation-dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated current","volume":"550","author":"Eisenman","year":"2003","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib13","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1529\/biophysj.107.118455","article-title":"Stoichiometric pore mutations of the GABAAR reveal a pattern of hydrogen bonding with picrotoxin","volume":"94","author":"Erkkila","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/ejn.12534","article-title":"GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system","volume":"39","author":"Fritschy","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib1a","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7829","article-title":"The desensitisation gate of inhibitory Cys-loop receptors","volume":"6","author":"Gielen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1113\/jphysiol.2007.134460","article-title":"The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus","volume":"582","author":"Glykys","year":"2007","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib17","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0026-895X(25)13351-8","article-title":"Role of the \u03b2 subunit in determining the pharmacology of human \u03b3-aminobutyric acid type A receptors","volume":"44","author":"Hadingham","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10139","article-title":"Principles of activation and permeation in an anion-selective Cys-loop receptor","volume":"474","author":"Hibbs","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0028-3908(96)00089-5","article-title":"A\u00a0functional comparison of the antagonists bicuculline and picrotoxin at recombinant GABAA receptors","volume":"35","author":"Krishek","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0026-895X(25)08736-X","article-title":"Homomeric \u03b21 \u03b3-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties","volume":"49","author":"Krishek","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib2a","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.127365","article-title":"Neuroactive steroids and human recombinant rho1 GABA receptors","volume":"323","author":"Li","year":"2007","journal-title":"J. Pharmacol. & Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nsmb.3477","article-title":"Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites","volume":"24","author":"Laverty","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(87)91394-1","article-title":"Pregnenolone-sulfate: an endogenous antagonist of the \u03b3-aminobutyric acid receptor complex in brain?","volume":"404","author":"Majewska","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0304-3940(88)90202-9","article-title":"Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons","volume":"90","author":"Majewska","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0922-4106(90)90124-G","article-title":"Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor","volume":"189","author":"Majewska","year":"1990","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nsmb.3484","article-title":"Structural basis for GABAA receptor potentiation by neurosteroids","volume":"24","author":"Miller","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1023\/A:1012376215967","article-title":"Distinguishing between GABAA receptors responsible for tonic and phasic conductances","volume":"26","author":"Mody","year":"2001","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0026-895X(24)12537-0","article-title":"Differential modulation of the \u03b3-aminobutyric acid type C receptor by neuroactive steroids","volume":"56","author":"Morris","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1113\/jphysiol.2003.054734","article-title":"Activation of single heteromeric GABAA receptor ion channels by full and partial agonists","volume":"557","author":"Mortensen","year":"2004","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1113\/jphysiol.2009.182444","article-title":"Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors","volume":"588","author":"Mortensen","year":"2010","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/35067500","article-title":"Constructing inhibitory synapses","volume":"2","author":"Moss","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1113\/jphysiol.1992.sp018998","article-title":"On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat","volume":"447","author":"Newland","year":"1992","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(99)01381-5","article-title":"Sulfated and unsulfated steroids modulate \u03b3-aminobutyric acidA receptor function through distinct sites","volume":"830","author":"Park-Chung","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2006.07.039","article-title":"Neurosteroid modulation of recombinant rat \u03b15\u03b22\u03b32L and \u03b11\u03b22\u03b32L GABAA receptors in Xenopus oocyte","volume":"547","author":"Rahman","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.apha.2014.10.006","article-title":"Inhibitory neurosteroids and the GABAA receptor","volume":"72","author":"Seljeset","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib35","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.20-10-03571.2000","article-title":"Pregnenolone sulfate modulates inhibitory synaptic transmission by enhancing GABAA receptor desensitization","volume":"20","author":"Shen","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib36","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib37","series-title":"Handbook of Ion Channels","first-page":"345","article-title":"GABAA receptors","author":"Smart","year":"2015"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1124\/mol.107.034058","article-title":"The neurosteroids dehydroepiandrosterone sulfate and pregnenolone sulfate inhibit the UNC-49 GABA receptor through a common set of residues","volume":"72","author":"Twede","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/ncb1801","article-title":"Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells","volume":"10","author":"Wagner","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib40","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.22-09-03366.2002","article-title":"3\u03b2-Hydroxypregnane steroids are pregnenolone sulfate-like GABAA receptor antagonists","volume":"22","author":"Wang","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1748-1716.2006.01617.x","article-title":"Pregnenolone sulphate and Zn2+ inhibit recombinant rat GABAA receptor through different channel property","volume":"188","author":"Wang","year":"2006","journal-title":"Acta Physiol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib51","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2006.11.071","article-title":"3\u03b2-hydroxysteroids and pregnenolone sulfate inhibit recombinant rat GABAA receptor through different channel property","volume":"557","author":"Wang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.bjp.0706719","article-title":"Residues in the first transmembrane domain of the Caenorhabditis elegans GABAA receptor confer sensitivity to the neurosteroid pregnenolone sulfate","volume":"148","author":"Wardell","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/6313","article-title":"Channel opening locks agonist onto the GABAC receptor","volume":"2","author":"Weiss","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib44","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1523\/JNEUROSCI.22-05-01541.2002","article-title":"Enhanced neurosteroid potentiation of ternary GABAA receptors containing the \u03b4 subunit","volume":"22","author":"Wohlfarth","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib45","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1460-9568.1997.tb01641.x","article-title":"Pharmacological and physiological characterization of murine homomeric \u03b23 GABAA receptors","volume":"9","author":"Wooltorton","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib46","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0006-3495(95)80056-1","article-title":"Interaction of picrotoxin with GABAA receptor channel-lining residues probed in cysteine mutants","volume":"69","author":"Xu","year":"1995","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1113\/jphysiol.1993.sp019643","article-title":"Multiple mechanisms of picrotoxin block of GABA-induced currents in rat hippocampal neurons","volume":"464","author":"Yoon","year":"1993","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0922-4106(92)90106-6","article-title":"Effects of subunit types of the recombinant GABAA receptor on the response to a neurosteroid","volume":"225","author":"Zaman","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.008_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1113\/jphysiol.1994.sp020278","article-title":"A\u00a0unique amino acid of the Drosophila GABA receptor with influence on drug sensitivity by two mechanisms","volume":"479","author":"Zhang","year":"1994","journal-title":"J.\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.02.008_bib50","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1523\/JNEUROSCI.16-21-06648.1996","article-title":"Delta subunit inhibits neurosteroid modulation of GABAA receptors","volume":"16","author":"Zhu","year":"1996","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:33:22Z","timestamp":1751394802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818300650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":53,"alternative-id":["S0028390818300650"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.008","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing GABAA receptors with inhibitory neurosteroids","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}